6/6/2025AstraZeneca's Imfinzi Approved in China for LS‑SCLC

6/6/2025Keymed Launches First-in-Human Trial of CM518D1

6/6/2025AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...

6/6/2025Kelun‑Biotech Initiates Phase II Trial of PTK7‑Targeted ADC SKB518 i...

6/6/2025Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...

6/5/2025CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia

6/5/2025Ascletis's Denifanstat Shows Promising Results in Phase III Acne Trial

6/4/2025Biocytogen and CTTQ Receive IND Approval in China for Next-Gen Anti-IG...

6/4/2025China Approves First Homegrown 9-Valent HPV Vaccine

6/4/2025Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...

6/3/2025Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

6/2/2025ArkBio's AK3280 Shows Significant Phase II Efficacy in IPF

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...

5/29/2025Rona Unveils Promising Preclinical Data for Annual RNAi Therapy

5/29/2025China Grants Conditional Approval to Hengrui's Famitinib

5/29/2025China Approves Zelgen's Gecacitinib

5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...

Page:17/22 Total number of articles:647: [First][<<] [15] [16] [17] [18] [19] [>>] [End]